Juniper Pharma (JNP) Tops Q3 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. CRGY
5. LULU
6. PEP
7. DVN
8. ANGO
9. BCO
10. NATL

Go back to Juniper Pharma (JNP) Tops Q3 EPS by 4c

Juniper Pharmaceuticals Reports Third Quarter 2017 Financial and Operating Results

November 2, 2017 4:05 PM EDT

BOSTON, Nov. 2, 2017 /PRNewswire/ -- Juniper Pharmaceuticals (Nasdaq: JNP), a diversified healthcare company focused on women's health, today announced financial results for the three-month period ended September 30, 2017. Cash and cash equivalents were $22.1 million at September 30, 2017, an increase of 3% from June 30, 2017.

"During the third quarter, we delivered robust revenue growth for our core businesses, CRINONE® and Juniper Pharma Services (JPS), which resulted in positive cash flow for the quarter. Our third quarter G&A expense has decreased to align closer to 2016 expenses," said Alicia Secor, Chief Executive Officer. "The strength in our core... More